Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial


Por: Martinez-Zapata, MJ, Orozco, L, Balius, R, Soler, R, Bosch, A, Rodas, G, Til, L, Peirau, X, Urrutia, G, Gich, I, Bonfill, X

Publicada: 1 ene 2016
Resumen:
Background. The goals of the treatment of muscle injuries are to shorten the time of healing and to avoid relapses. The aim of this study was to assess the efficacy of autologous platelet-rich plasma (PRP) in the healing of muscle injuries. Materials and methods. A multicentre, randomised, double-blind, parallel, controlled clinical trial was conducted in 71 patients (81.8% males) aged 45.6 (SD=10.0) years with muscle tears in the legs and haematoma. The haematoma was evacuated in all patients. Thirty-three patients were randomised to a single dose of autologous PRP and 38 patients to simulation of PRP administration. The primary end-point was time to complete recovery of muscle injury. Secondary end-points were pain, relapses, ultrasound parameters, and adverse events. The total follow-up per patient was 12 months. Results. Time to complete recovery after the treatment was 31.63 days (SD=15.38) in the PRP group, and 38.43 days (SD=18.58) in the control group (p=0.261). Pain decreased over time in both groups without statistical differences between them. Eight patients relapsed (seven in the control group, and one in the PRP group). There were no adverse effects related to the interventions. Discussion. Autologous PRP did not significantly improve the time to healing compared to that in the control group.

Filiaciones:
Martinez-Zapata, MJ:
 IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain

 CIBER Epidemiol & Publ Hlth, Barcelona, Spain

Orozco, L:
 Quiron Teknon Hosp, ITRT, C Vilana 12, Barcelona 08022, Spain

Balius, R:
 Generalitat Catalunya, Sport Catalan Council, Barcelona, Spain

Soler, R:
 Quiron Teknon Hosp, ITRT, C Vilana 12, Barcelona 08022, Spain

Bosch, A:
 Blood & Tissue Bank Catalonia, Barcelona, Spain

Rodas, G:
 Barcelona Football Club, Med Serv, Barcelona, Spain

Til, L:
 Barcelona Football Club, Med Serv, Barcelona, Spain

 Hlth Consortium Terrassa, High Performance Ctr, Barcelona, Spain

Peirau, X:
 Vithas Montserrat Hosp, Catalunya Natl Inst Phys Educ, Lleida, Spain

Urrutia, G:
 IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain

 CIBER Epidemiol & Publ Hlth, Barcelona, Spain

Gich, I:
 CIBER Epidemiol & Publ Hlth, Barcelona, Spain

 Autonomous Univ Barcelona, Clin Epidemiol & Publ Hlth Dept, Hosp Santa Creu & St Pau, Barcelona, Spain

Bonfill, X:
 IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain

 CIBER Epidemiol & Publ Hlth, Barcelona, Spain

 Autonomous Univ Barcelona, Clin Epidemiol & Publ Hlth Dept, Hosp Santa Creu & St Pau, Barcelona, Spain
ISSN: 17232007





Blood Transfusion
Editorial
SIMTIPRO SRL, VIA DESIDERIO 21, MILAN, 20131, ITALY, Italia
Tipo de documento: Article
Volumen: 14 Número: 3
Páginas: 245-254
WOS Id: 000378619800010
ID de PubMed: 26509827

MÉTRICAS